Soto, Sara et al. published their research in Organic & Biomolecular Chemistry in 2012 |CAS: 152213-63-3

The Article related to aminoarylboronic acid iodoindoleacetate suzuki amidation, Heterocyclic Compounds (One Hetero Atom): Higher-Membered Rings and other aspects.Category: indole-building-block

Soto, Sara; Vaz, Esther; Dell’Aversana, Carmela; Alvarez, Rosana; Altucci, Lucia; de Lera, Angel R. published an article in 2012, the title of the article was New synthetic approach to paullones and characterization of their SIRT1 inhibitory activity.Category: indole-building-block And the article contains the following content:

A series of 7,12-dihydroindolo[3,2-d][1]benzazepine-6(5H)-ones (paullones) substituted at C9/C10 (Br) and C2 (Me, CF3, CO2Me) have been synthesized by a one-pot Suzuki-Miyaura cross-coupling of an o-aminoarylboronic acid and Me 2-iodoindoleacetate followed by intramol. amide formation. Other approaches to the paullone scaffold based on Pd-catalyzed C-H activation were unsuccessful. In vitro enzymic assay with recombinant human SIRT-1 indicated a strong inhibitory profile for the series, in particular the analog with a methoxycarbonyl group at C2 and a bromine at C9. These compounds are, in general, inducers of granulocyte differentiation of the U937 acute leukemia cell line and cause a marked increase in pre-G1 of the cell cycle. The experimental process involved the reaction of Methyl 2-(6-bromo-1H-indol-3-yl)acetate(cas: 152213-63-3).Category: indole-building-block

The Article related to aminoarylboronic acid iodoindoleacetate suzuki amidation, Heterocyclic Compounds (One Hetero Atom): Higher-Membered Rings and other aspects.Category: indole-building-block

Referemce:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Khan, Pasha M. et al. published their research in ACS Medicinal Chemistry Letters in 2011 |CAS: 879562-21-7

The Article related to indoline tetrahydroisoquinoline aminobenzimidazole preparation, structure activity relationship pharmacokinetics nod1 induced nfkappab activation inhibitor, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Category: indole-building-block

On October 13, 2011, Khan, Pasha M.; Correa, Ricardo G.; Divlianska, Daniela B.; Peddibhotla, Satyamaheshwar; Sessions, E. Hampton; Magnuson, Gavin; Brown, Brock; Suyama, Eigo; Yuan, Hongbin; Mangravita-Novo, Arianna; Vicchiarelli, Michael; Su, Ying; Vasile, Stefan; Smith, Layton H.; Diaz, Paul W.; Reed, John C.; Roth, Gregory P. published an article.Category: indole-building-block The title of the article was Identification of Inhibitors of NOD1-Induced Nuclear Factor-κB Activation. And the article contained the following:

NOD1 (nucleotide-binding oligomerization domain 1) protein is a member of the NLR (NACHT and leucine rich repeat domain containing proteins) protein family, which plays a key role in innate immunity as a sensor of specific microbial components derived from bacterial peptidoglycans and induction of inflammatory responses. Mutations in NOD proteins have been associated with various inflammatory diseases that affect NF-κB (nuclear factor κB) activity, a major signaling pathway involved in apoptosis, inflammation, and immune response. A luciferase-based reporter gene assay was utilized in a high-throughput screening program conducted under the NIH-sponsored Mol. Libraries Probe Production Center Network program to identify the active scaffolds. Herein, we report the chem. synthesis, structure-activity relationship studies, downstream counterscreens, secondary assay data, and pharmacol. profiling of the 2-aminobenzimidazole lead, I, as a potent and selective inhibitor of NOD1-induced NF-κB activation. The experimental process involved the reaction of 1-(Cyclopropanecarbonyl)indoline-5-sulfonyl chloride(cas: 879562-21-7).Category: indole-building-block

The Article related to indoline tetrahydroisoquinoline aminobenzimidazole preparation, structure activity relationship pharmacokinetics nod1 induced nfkappab activation inhibitor, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Category: indole-building-block

Referemce:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Sikorska, Emilia et al. published their research in Chemical Biology & Drug Design in 2012 |CAS: 79815-20-6

The Article related to arginine vasopressin proline derivative nmr mol modeling conformation preference, Mammalian Hormones: Structure and Structure-Activity Relations and other aspects.Recommanded Product: H-Idc-OH

On April 30, 2012, Sikorska, Emilia; Sobolewski, Dariusz; Kwiatkowska, Anna published an article.Recommanded Product: H-Idc-OH The title of the article was Conformational preferences of proline derivatives incorporated into vasopressin analogues: NMR and molecular modelling studies. And the article contained the following:

In this study, arginine vasopressin analogs modified with proline derivatives – indoline-2-carboxylic acid (Ica), (2S,4R)-4-(naphthalene-2-ylmethyl)pyrrolidine-2-carboxylic acid (Nmp), (2S,4S)-4-aminopyroglutamic acid (APy) and (2R,4S)-4-aminopyroglutamic acid, (Apy) – were examined using NMR spectroscopy and mol. modeling methods. The results have shown that Ica is involved in the formation of the cis peptide bond. Moreover, it reduces to a great extent the conformational flexibility of the peptide. In turn, incorporation of (2S,4R)-Nmp stabilizes the backbone conformation, which is heavily influenced by the pyrrolidine ring. However, the aromatic part of the Nmp side chain exhibits a high degree of conformational freedom. With analogs [(2S,4S)-4-aminopyroglutamic acid2-3]AVP and [(2R,4S)-4-aminopyroglutamic acid2-3]AVP, introduction of the 4-aminopyroglutamic acid reduces locally conformational space of the peptides, but it also results in weaker interactions with the dodecylphosphocholine/SDS micelle. Admittedly, both analogs are adsorbed on the micelle’s surface but they do not penetrate into its core. With analog [(2R,4S)-4-aminopyroglutamic acid2-3]AVP, the interactions between the peptide and the micelle seem to be so weak that conformational equilibrium is established between different bound states. The experimental process involved the reaction of H-Idc-OH(cas: 79815-20-6).Recommanded Product: H-Idc-OH

The Article related to arginine vasopressin proline derivative nmr mol modeling conformation preference, Mammalian Hormones: Structure and Structure-Activity Relations and other aspects.Recommanded Product: H-Idc-OH

Referemce:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Okano, Tsubasa et al. published their patent in 2015 |CAS: 52537-00-5

The Article related to imidazoline preparation selective adrenaline alpha 1a receptor full agonist, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Product Details of 52537-00-5

On November 5, 2015, Okano, Tsubasa; Suzuki, Shinya published a patent.Product Details of 52537-00-5 The title of the patent was Preparation of imidazoline derivatives as selective adrenaline α1A receptor full agonists. And the patent contained the following:

Disclosed are compounds I [A = Q1, Q2 or Q3; R = halo; n = 1-4; or pharmaceutically acceptable salts thereof]. For example, II·2HCl was prepared via reaction of 5-chloroindolin-2-one with TMEDA/n-BuLi/1,2-dibromoethane, reduction, cyanomethylation with bromoacetonitrile, treatment with ethylenediamine/P2S5 and salt-formation. In adrenaline receptor α1 agonist activity test, the exemplified compound II·2HCl showed EC50 values (nmol/L) of 2.60 and >10000 for α1A and α1L, resp. The experimental process involved the reaction of 6-Chloro-2,3-dihydro-1H-indole(cas: 52537-00-5).Product Details of 52537-00-5

The Article related to imidazoline preparation selective adrenaline alpha 1a receptor full agonist, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Product Details of 52537-00-5

Referemce:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Goergler, Annick et al. published their patent in 2019 |CAS: 52537-00-5

The Article related to dihydrobenzimidazolone preparation anticancer crbn protein degradation, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.COA of Formula: C8H8ClN

On March 7, 2019, Goergler, Annick; Norcross, Roger; Dey, Fabian; Kusznir, Eric Andre published a patent.COA of Formula: C8H8ClN The title of the patent was Dihydrobenzimidazolones as anticancer agents and their preparation. And the patent contained the following:

The invention provides compounds of formula I which bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and alter the substrate specificity of the CRBN E3 ubiquitin ligase complex, resulting in breakdown of intrinsic downstream proteins. Compounds of formula I are thus useful for the treatment of various cancers. Compounds of formula I wherein X1 and X2 are independently H, and C1-6 alkyl; W1, W2 and W3 are independently CH and N, provided that if one of W1 – W3 is N, then the other two are CH; Z is absent, (CH2)1-3, (CH2)0-2O(CH2)0-2, etc.; A is (un)substituted aryl, (un)substituted heteroaryl, (un)substituted heterocyclyl, etc.; and pharmaceutically acceptable salts thereof, are claimed. Example compound II was prepared by amination of 4-fluoro-N-methyl-3-nitrobenzamide with 5-amino-1H-benzo[d]imidazol-2(3H)-one; the resulting N-methyl-3-nitro-4-((2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)amino)benzamide underwent hydrogenation to give compound II. The invention compounds were evaluated for their CRBN binding affinity. From the assay, it was determined that compound II exhibited Kd value of 0.587 μM. The experimental process involved the reaction of 6-Chloro-2,3-dihydro-1H-indole(cas: 52537-00-5).COA of Formula: C8H8ClN

The Article related to dihydrobenzimidazolone preparation anticancer crbn protein degradation, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.COA of Formula: C8H8ClN

Referemce:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Karjee, Pallab et al. published their research in Journal of Organic Chemistry in 2020 |CAS: 52537-00-5

The Article related to stereospecific oxidative annulative coupling indoline aziridine, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Application of 52537-00-5

On June 19, 2020, Karjee, Pallab; Sarkar, Tanumay; Kar, Subhradeep; Punniyamurthy, Tharmalingam published an article.Application of 52537-00-5 The title of the article was Transition-Metal-Free Stereospecific Oxidative Annulative Coupling of Indolines with Aziridines. And the article contained the following:

Tandem C-N bond formation for the oxidative annulation of indolines with aziridines is accomplished employing the combination of DDQ and NaOCl at ambient conditions. Optically active aziridine can be coupled with high enantiomeric purity (>99% ee). The substrate scope, stereocontrol with the enantioenriched substrate, and scale-up are the important practical advantages. The experimental process involved the reaction of 6-Chloro-2,3-dihydro-1H-indole(cas: 52537-00-5).Application of 52537-00-5

The Article related to stereospecific oxidative annulative coupling indoline aziridine, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Application of 52537-00-5

Referemce:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Li, Jie et al. published their research in Letters in Organic Chemistry in 2019 |CAS: 79815-20-6

The Article related to bicyclic pyrroloimidazole preparation, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Safety of H-Idc-OH

On December 31, 2019, Li, Jie; Yao, Jiaqi; He, Weiping; Yang, Fan; Liu, Xiaoming published an article.Safety of H-Idc-OH The title of the article was Modular Synthesis of New Bicyclic Carbene Precursors. And the article contained the following:

A series of new N-heterocyclic carbene (NHC) precursors, containing bicyclic pyrrolo[1,2-c]imidazole framework, were prepared from N-(tert-butoxycarbonyl)-L-proline (1-Boc-L-proline). The sequential attachment of nitrogen nucleophiles and subsequent ring closure gave the desired bicyclic NHC precursors in good yields. The structures of these new NHC precursors were determined on the basis of spectroscopic techniques, including NMR and MS. The experimental process involved the reaction of H-Idc-OH(cas: 79815-20-6).Safety of H-Idc-OH

The Article related to bicyclic pyrroloimidazole preparation, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Safety of H-Idc-OH

Referemce:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Tran, Duc N. et al. published their research in Organic Process Research & Development in 2022 |CAS: 79815-20-6

The Article related to odalasvir preparation, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Electric Literature of 79815-20-6

On March 18, 2022, Tran, Duc N.; Zhdanko, Alexander; Barroso, Santiago; Nieste, Patrick; Rahmani, Ramdane; Holan, Jan; Hoefnagels, Roel; Reniers, Peter; Vermoortele, Frederik; Duguid, Stewart; Cazanave, Lionel; Figlus, Marek; Muir, Colin; Elliott, Alain; Zhao, Peichao; Paden, Warren; Diaz, Cristina Hernandez; Bell, Stephen J.; Hashimoto, Akihiro; Phadke, Avinash; Wiles, Jason A.; Vogels, Ilse; Farina, Vittorio published an article.Electric Literature of 79815-20-6 The title of the article was Development of a Commercial Process for Odalasvir. And the article contained the following:

Odalasvir is a selective inhibitor of hepatitis C virus NS5A protein, a key target for combination therapies. This paper described the chem. process development for the synthesis of this API and the improvements that were achieved over the medicinal chem. Optimization of all the reaction conditions and crystallizations resulted in higher throughput and a highly improved process mass intensity (PMI). The process was robust and it was scaled up to ∼100 kg batches without issues. The experimental process involved the reaction of H-Idc-OH(cas: 79815-20-6).Electric Literature of 79815-20-6

The Article related to odalasvir preparation, Heterocyclic Compounds (More Than One Hetero Atom): Imidazoles and other aspects.Electric Literature of 79815-20-6

Referemce:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Teegarden, Bradley et al. published their patent in 2007 |CAS: 52537-00-5

The Article related to primary amine preparation 5ht2a serotonin receptor modulator treatment disease, pyrazolylphenyl amine preparation 5ht2a serotonin receptor modulator treatment disease, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazoles and other aspects.Related Products of 52537-00-5

On November 29, 2007, Teegarden, Bradley; Chapman, Dennis; Choi, Juyi; Feichtinger, Konrad; Han, Sangdon; Jayakumar, Honnappa; Tran, Thuy-Anh; Xu, Jingdong; Zou, Ning published a patent.Related Products of 52537-00-5 The title of the patent was Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto and their preparation. And the patent contained the following:

The present invention pertains to certain compounds of formula I and pharmaceutical compositions thereof that modulate the activity of the 5-HT2A serotonin receptor. Compounds and pharmaceutical compositions thereof are directed to methods useful in the treatment of platelet aggregation, sleep disorders, diabetic-related disorders, progressive multifocal leukoencephalopathy hypertension and pain. The invention also relates to the methods for the treatment of 5-HT2A serotonin receptor associated disorders in combination with other pharmaceutical agents administered sep. or together. Compounds of formula I wherein X is O and S; V is O and NH; W and Z are independently (un)substituted C1-4 alkylene; R1 is H, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, and C3-7 cycloalkyl; R2 is H, C1-6 acyl, C1-6 acyloxy, C2-6 alkenyl, C1-6 alkoxy, C1-6 alkyl, etc.; R3 is H, C2-6 alkenyl, C1-6 alkyl, C1-6 alkylcarboxamide, C2-6 alkynyl, carboxamide, CN, etc.; R4a is H, R4b is H, (un)substituted C1-12 acyl, (un)substituted carbo-C1-6 alkoxy, (un)substituted CO2-aryl, etc.; R5, R6 and R7 are independently H, C1-6 acyl, C1-6 acyloxy, C2-6 alkenyl, C1-6 alkoxy, C1-6 alkyl, etc.; R8 is (un)substituted C1-8 alkyl, (un)substituted (hetero)aryl, (un)substituted C3-10 cycloalkyl and (un)substituted heterocyclyl; and their pharmaceutically acceptable salts, hydrates, and solvates thereof, are claimed. Example compound II•TFA was prepared by a general procedure (procedure given). All the invention compounds were evaluated for their 5-HT2A modulatory activity (some data given). The experimental process involved the reaction of 6-Chloro-2,3-dihydro-1H-indole(cas: 52537-00-5).Related Products of 52537-00-5

The Article related to primary amine preparation 5ht2a serotonin receptor modulator treatment disease, pyrazolylphenyl amine preparation 5ht2a serotonin receptor modulator treatment disease, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazoles and other aspects.Related Products of 52537-00-5

Referemce:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles

Li, Jinping et al. published their patent in 2021 |CAS: 52537-00-5

The Article related to preparation rock inhibitor medical application, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazoles and other aspects.Recommanded Product: 6-Chloro-2,3-dihydro-1H-indole

On May 20, 2021, Li, Jinping; Lou, Jun; Guo, Xiaodan; Zeng, Xian; Chen, Yongkai; Zhang, Yihan; Peng, Wei; Wang, Chaodong published a patent.Recommanded Product: 6-Chloro-2,3-dihydro-1H-indole The title of the patent was Preparation of the rock inhibitor and their medical applications. And the patent contained the following:

The invention is related to the preparation of the rock inhibitor I and their medical applications. The invention compounds I, wherein W and V are independently C or N;X is -C (=0) NRx-, -NRx-C (=O); Y is a chem. bond, or unsubstituted or optionally substituted by one, two or more Ry groups, etc.; ring A is unsubstituted or optionally substituted with one, etc.; ring B is unsubstituted or optionally substituted by one, etc.; ring C is unsubstituted or optionally substituted by one, two or more Rc groups as follows: C3_20 alicyclic hydrocarbon group, 3-20 no heterocyclic group, C6-20 aryl or 5-20 membered heteroaryl; ring D is the following group unsubstituted or optionally substituted by one, two or more Rd: C3_20 alicyclic hydrocarbon group, 3-20 membered heterocyclic group,C6_2() aryl or 5-20 membered heteroaryl; Ry, Rab, Rc, Rd are each independently selected from H, halogen, nitro, nitroso, etc.; and their racemates, stereoisomers, tautomers, isotopic markers, nitrogen oxides, solvates, polymorphs, metabolites, esters, pharmaceutically acceptable salts, or prodrugs are claimed. Compound I was prepared by multi-step procedure (procedure given). The invention compounds I were evaluated for their ROCK inhibitory activity. The experimental process involved the reaction of 6-Chloro-2,3-dihydro-1H-indole(cas: 52537-00-5).Recommanded Product: 6-Chloro-2,3-dihydro-1H-indole

The Article related to preparation rock inhibitor medical application, Heterocyclic Compounds (More Than One Hetero Atom): Pyrazoles and other aspects.Recommanded Product: 6-Chloro-2,3-dihydro-1H-indole

Referemce:
Indole alkaloid derivatives as building blocks of natural products from Bacillus thuringiensis and Bacillus velezensis and their antibacterial and antifungal activity study,
Preparation of Indole Containing Building Blocks for the Regiospecific Construction of Indole Appended Pyrazoles and Pyrroles